{"id":"antiperspirant","rwe":[],"_fda":{"id":"26454eb2-2efd-f603-e063-6394a90a76d5","set_id":"0024658a-0b42-790f-e063-6294a90aefe8","openfda":{"unii":["UCN889409V"],"route":["TOPICAL"],"spl_id":["26454eb2-2efd-f603-e063-6394a90a76d5"],"brand_name":["Dove"],"spl_set_id":["0024658a-0b42-790f-e063-6294a90aefe8"],"package_ndc":["64942-2138-1"],"product_ndc":["64942-2138"],"generic_name":["EVEN TONE PLUS NIACINAMIDE APPLE BLOSSOM AND MANGO BUTTER DRY SPRAY 72H ANTIPERSPIRANT DEODORANT"],"product_type":["HUMAN OTC DRUG"],"substance_name":["ALUMINUM SESQUICHLOROHYDRATE"],"manufacturer_name":["Conopco, Inc. d/b/a Unilever"],"application_number":["M019"],"is_original_packager":[true]},"purpose":["Purpose antiperspirant"],"version":"2","warnings":["Warnings • FLAMMABLE. DO NOT USE NEAR HEAT, FLAME, OR WHILE SMOKING. CAN CAUSE SERIOUS INJURY OR DEATH • Keep away from face and mouth to avoid breathing in. • Avoid spraying in eyes. Contents under pressure. Do not puncture or incinerate. Do not expose to heat or store at temperatures above 120°F/50°C or in enclosed places that could overheat • Do not use on broken skin. Stop use if rash or irritation occurs. • Ask a doctor before using if you have kidney disease. • USE ONLY AS DIRECTED. INTENTIONAL MISUSE BY DELIBERATELY CONCENTRATING AND INHALING THE CONTENTS CAN BE HARMFUL OR FATAL. Help stop inhalation abuse. For information visit www.inhalant.org"],"questions":["Questions? Call 1-800-761-3683"],"description":["DOVE EVEN TONE+ NIACINAMIDE APPLE BLOSSOM & MANGO BUTTER DRY SPRAY 72H ANTIPERSPIRANT DEODORANT - aluminum sesquichlorohydrate aerosol, spray"],"effective_time":"20241106","active_ingredient":["Drug Facts Active ingredient Aluminum Sesquichlorohydrate (12.2)"],"inactive_ingredient":["Inactive ingredients Butane, Hydrofluorocarbon 152a, Cyclopentasiloxane, Isobutane, PPG-14 Butyl Ether, Isopropyl Isostearate, Glycine, Helianthus Annuus (Sunflower) Seed Oil, C12-15 Alkyl Benzoate, Disteardimonium Hectorite, Fragrance (Parfum), Calcium Chloride, Propane, BHT, Octyldodecanol, Propylene Carbonate, Dimethiconol, Niacinamide"],"indications_and_usage":["Uses • reduces underarm wetness"],"dosage_and_administration":["Directions apply to underarms only"],"spl_product_data_elements":["Dove Even Tone plus Niacinamide Apple Blossom and Mango Butter Dry Spray 72H Antiperspirant Deodorant CALCIUM CHLORIDE 1,1-DIFLUOROETHANE GLYCINE BUTANE CYCLOMETHICONE 5 ISOBUTANE PPG-14 BUTYL ETHER SUNFLOWER OIL DISTEARDIMONIUM HECTORITE ALKYL (C12-15) BENZOATE PROPANE BUTYLATED HYDROXYTOLUENE OCTYLDODECANOL PROPYLENE CARBONATE DIMETHICONOL (40 CST) ALUMINUM SESQUICHLOROHYDRATE ALUMINUM SESQUICHLOROHYDRATE ISOPROPYL ISOSTEARATE NIACINAMIDE"],"keep_out_of_reach_of_children":["• KEEP OUT OF REACH OF CHILDREN"],"package_label_principal_display_panel":["Dove Apple Blossom Dry Spray AP"]},"tags":[],"safety":{"boxedWarnings":[]},"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=antiperspirant","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:18:57.844855+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T02:19:13.928188+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:19:03.543135+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=antiperspirant","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:19:03.923711+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T02:18:56.714075+00:00"},"indications.approved":{"url":"","method":"ai_extraction","source":"FDA Label + AI","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"fda_label","retrievedAt":"2026-04-20T02:19:09.659007+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T02:18:56.714109+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"M019","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T02:18:56.714114+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"19134cb0-d09a-af75-e063-6394a90a08e8","title":"DEGREE (ADVANCED SAGE AND OCEAN MIST 72H ANTIPERSPIRANT DEODORANT) STICK [CONOPCO INC. D/B/A/ UNILEVER]"},"aiSummary":"The antiperspirant developed by the University of Wisconsin, Madison is currently marketed and primarily indicated for reducing underarm wetness. A key strength is the protection provided by a key composition patent, which is set to expire in 2028. The primary risk is the potential increase in competition following the patent expiry.","ecosystem":[],"_scrapedAt":"2026-03-28T02:59:25.719Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T02:19:13.928263+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"indications":{"approved":[{"id":"antiperspirant-reduces-underarm-wetness","name":"Reduces underarm wetness","dosing":null,"approvals":[],"diseaseId":"","eligibility":null,"pivotalTrial":null,"restrictions":[],"patientPopulation":null,"diagnosticRequired":null,"brandNameForIndication":""}]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06881394","phase":"NA","title":"A Polymer Film Device to Treat Excessive Palmar Sweating","status":"RECRUITING","sponsor":"Miller Biosciences LLC","startDate":"2024-07-03","conditions":"Palmar Hyperhidrosis","enrollment":30},{"nctId":"NCT05501444","phase":"NA","title":"Antiperspirant in the Treatment of Residual Limp Hyperhidrosis for Prosthetic Users","status":"COMPLETED","sponsor":"Sophies Minde Ortopedi","startDate":"2022-08-09","conditions":"Hyperhidrosis, Residual Limbs","enrollment":7},{"nctId":"NCT03236012","phase":"PHASE1","title":"Hyperhidrosis in Patients With Amputations-Botox","status":"COMPLETED","sponsor":"University of Utah","startDate":"2019-01-08","conditions":"Hyperhidrosis","enrollment":25},{"nctId":"NCT00992706","phase":"PHASE3","title":"F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer","status":"COMPLETED","sponsor":"Swiss Cancer Institute","startDate":"2009-09","conditions":"Breast Cancer, Palmar-plantar Erythrodysesthesia","enrollment":91},{"nctId":"NCT00213993","phase":"PHASE2","title":"Topical Antiperspirant for Hand-Foot Syndrome","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2005-05","conditions":"Palmar-plantar Erythrodysesthesia","enrollment":14},{"nctId":"NCT00509886","phase":"NA","title":"Non-prescription Versus Prescription Topical Treatments Versus no Treatment in the Control of Sweating","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2007-06","conditions":"Hyperhidrosis, Excess Sweating","enrollment":24},{"nctId":"NCT01725451","phase":"PHASE1","title":"A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2012-11","conditions":"Healthy Participants","enrollment":30},{"nctId":"NCT00857168","phase":"PHASE1","title":"To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion","status":"COMPLETED","sponsor":"Acrux DDS Pty Ltd","startDate":"2009-01","conditions":"Hypogonadism","enrollment":36}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Topical"},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":241,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"antiperspirant","genericName":"antiperspirant","companyName":"University of Wisconsin, Madison","companyId":"university-of-wisconsin-madison","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T02:19:13.928263+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}